Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CENOBAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CENOBAMATE: Safety Overview

Metric CEMIPLIMAB CENOBAMATE
Total FAERS Reports 1,020 5,643
Deaths Reported 175 125
Death Rate 17.2% 2.2%
Hospitalizations 651 1,012
Average Patient Age 68.9 yrs 38.2 yrs
% Female Patients 36.6% 56.4%
FDA Approval Date N/A Mar 10, 2020
Manufacturer Regeneron Pharmaceuticals, Inc. SK Life Science, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription